U.S. flag

An official website of the United States government

NM_001904.4(CTNNB1):c.97T>C (p.Ser33Pro) AND Prostate adenocarcinoma

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
May 31, 2016
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000436119.2

Allele description [Variation Report for NM_001904.4(CTNNB1):c.97T>C (p.Ser33Pro)]

NM_001904.4(CTNNB1):c.97T>C (p.Ser33Pro)

Genes:
LOC126806658:BRD4-independent group 4 enhancer GRCh37_chr3:41265899-41267098 [Gene]
CTNNB1:catenin beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.1
Genomic location:
Preferred name:
NM_001904.4(CTNNB1):c.97T>C (p.Ser33Pro)
HGVS:
  • NC_000003.12:g.41224609T>C
  • NG_013302.2:g.30159T>C
  • NM_001098209.2:c.97T>C
  • NM_001098210.2:c.97T>C
  • NM_001330729.2:c.76T>C
  • NM_001904.4:c.97T>CMANE SELECT
  • NP_001091679.1:p.Ser33Pro
  • NP_001091680.1:p.Ser33Pro
  • NP_001317658.1:p.Ser26Pro
  • NP_001895.1:p.Ser33Pro
  • LRG_1108t1:c.97T>C
  • LRG_1108:g.30159T>C
  • LRG_1108p1:p.Ser33Pro
  • NC_000003.11:g.41266100T>C
Protein change:
S26P
Links:
dbSNP: rs1057519886
NCBI 1000 Genomes Browser:
rs1057519886
Molecular consequence:
  • NM_001098209.2:c.97T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001098210.2:c.97T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330729.2:c.76T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001904.4:c.97T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Prostate adenocarcinoma
Synonyms:
Adenocarcinoma of prostate
Identifiers:
MONDO: MONDO:0005082; MedGen: C0007112

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000506006Database of Curated Mutations (DoCM)
no assertion criteria provided
Likely pathogenic
(May 31, 2016) 		somaticliterature only

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS.

Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.

PubMed [citation]
PMID:
26619011
PMCID:
PMC4744099

Details of each submission

From Database of Curated Mutations (DoCM), SCV000506006.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024